The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020 | 12AM GMT | 12AM EST | 12AM PST

Not long until our post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥

🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊

Don’t miss your chance to register: http://ow.ly/5CEs50FuZ2i

@VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML

State-of-the-art #CART therapy for B-ALL, w/ Daniel Lee of @UVA:
http://ow.ly/M11C50FzWXk

@EHA_Hematology #EHA2021 #HemOnc #Leukemia #ImmunoOnc #ALLsm #Leusm

Not long until our post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥

🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊

Don’t miss your chance to register: http://ow.ly/1maz50FuYUk

@VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML

State-of-the-art treatment regimens for LR-MDS

Hear from Valeria Santini of @UNI_FIRENZE, who provides an overview of the treatment landscape for lower-risk MDS: http://ow.ly/SRF150FzWV4

@EHA_Hematology #EHA2021 #HemOnc #MDSsm

Join us for this upcoming webinar on Highlights from ASCO / EHA 2021: latest updates on myeloma
Click to register for this webinar (July 27, 2021):
https://us06web.zoom.us/webinar/register/WN_ZTjrZli-TC6QLfYpCh8ClQ

Load More...

EHA 2020

The 25th Congress of the European Hematology Association (EHA) 2020
11–21 June 2020

The 25th Congress of the European Hematology Association (EHA) 2020, 11–21 June, will see hematology experts from around the globe congregate online for a spectacular show of the latest research outputs.

Key data on novel agents, biomarkers, cellular therapy, patient-reported outcomes, genomic insights, transplant research, and more was showcased across the spectrum of hematological diseases, including CLL, AML, multiple myeloma, lymphomas, CML, ALL, sickle cell disease, VOD, ITP, PNH, thalessemia, and beyond.

View all videos

Not long until our post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥

🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊

Don’t miss your chance to register: http://ow.ly/5CEs50FuZ2i

@VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML

State-of-the-art #CART therapy for B-ALL, w/ Daniel Lee of @UVA:
http://ow.ly/M11C50FzWXk

@EHA_Hematology #EHA2021 #HemOnc #Leukemia #ImmunoOnc #ALLsm #Leusm

Not long until our post-EHA/ICML #CLLSession with Paolo Ghia, Susan O’Brien, Lydia Scarfo and @Othman_Al_Sawaf 🖥

🗓 Mon 26 July at 7pm CEST/6pm BST/1pm EDT📊

Don’t miss your chance to register: http://ow.ly/1maz50FuYUk

@VJHemOnc #VJSessions #CLLsm #Leusm #EHA21 #16ICML

State-of-the-art treatment regimens for LR-MDS

Hear from Valeria Santini of @UNI_FIRENZE, who provides an overview of the treatment landscape for lower-risk MDS: http://ow.ly/SRF150FzWV4

@EHA_Hematology #EHA2021 #HemOnc #MDSsm

Join us for this upcoming webinar on Highlights from ASCO / EHA 2021: latest updates on myeloma
Click to register for this webinar (July 27, 2021):
https://us06web.zoom.us/webinar/register/WN_ZTjrZli-TC6QLfYpCh8ClQ

Load More...

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter